Clin2
NCT06269536Possibly a fitRecruiting

Stress reduction program for muscle-invasive bladder cancer

Bladder Cancer

Part of Brain & nervous system, Cancer, Kidney & urinary, Mental health, Women’s health & pregnancy clinical trials.

This trial tests a stress-reducing program for people with muscle-invasive bladder cancer. It aims to see if lowering stress can help with treatment outcomes and quality of life.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older.
  • You have bladder cancer that has grown into the muscle layer of the bladder wall (confirmed by biopsy).
  • You have not had chemotherapy for this cancer before.
  • You have not had any other cancer (except a common skin cancer called basal cell carcinoma) in the past 5 years.
  • Your kidneys work well enough (creatinine clearance above 60 ml/min).
  • You have basic computer skills (like using a mouse, keyboard, and internet browser).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05790850Recruiting
Mindfulness and exercise plan before bladder surgery

This study tests whether a structured mindfulness and high-intensity exercise program before radical bladder surgery can help patients improve health and recovery. You may be asked to use monitoring devices and complete questionnaires during the study.

Charlottesville, Virginia
NCT06040762Recruiting
Get moving before bladder cancer surgery

This study tests whether a home-based exercise program before surgery can help improve physical function in people with bladder or upper tract urothelial cancer. If you are planning to have surgery to remove your bladder or upper urinary tract, you may be able to join.

Seattle, Washington
NCT06963346Recruiting· Phase 1
Bladder cancer trial: targeted drug plus immunotherapy before surgery

This trial tests a combination of a targeted drug (HDAC inhibitor, given directly into the bladder) and an immunotherapy (Durvalumab, given through a vein) before bladder removal surgery. It's for people with muscle-invasive bladder cancer who cannot take the chemo drug cisplatin.

Tampa, Florida
NCT05397262Recruiting
Bladder cancer treatment with radiation plus heat therapy

This trial studies adding “heat treatment” (hyperthermia) to standard bladder cancer care using radiation, sometimes with chemotherapy. It may help the radiation work better, but your eligibility depends on cancer stage, your general health, and certain heart and metal-safety issues.

Erlangen
NCT07043543Not yet recruiting
Adaptive radiation therapy for bladder cancer

This trial tests a new type of radiation therapy that adjusts to your body's changes during treatment. It aims to reduce side effects and improve accuracy for people with bladder cancer.

Dijon, Côte d'or
NCT07548476Recruiting
Acupuncture and exercise for nerve pain from cancer treatment

This study tests whether adding acupuncture and exercise can help prevent or reduce nerve pain, numbness, or tingling caused by a cancer treatment called EV-Pembro (a drug combination for bladder cancer). It may help you stay active and feel better during treatment.

Boston, Massachusetts

Hear when a new Bladder Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.